Addenbrooke's Cognitive Examination-Third Edition Predicts Neuropsychological Test Performance

Area of Science:

• Neuroscience
• Gerontology
• Cognitive Psychology

Background:

• Effective screening tools aid treatment decisions for neurocognitive disorders.
• Neuropsychological evaluations are the gold standard for assessing cognitive function in neurodegenerative diseases.
• The Addenbrooke's Cognitive Examination-Third Edition (ACE-III) is a widely used cognitive screening tool for older adults.

Purpose of the Study:

• To determine if performance on the ACE-III predicts subsequent performance on comprehensive neuropsychological evaluations.
• To assess the diagnostic accuracy of the ACE-III compared to full neuropsychological testing.
• To investigate the influence of educational attainment on ACE-III predictive performance.

Main Methods:

• 217 patients with neurocognitive concerns underwent neuropsychological evaluation, including the ACE-III.
• Regression analyses examined the predictive relationship between ACE-III subscales and neuropsychological measures.
• Logistic regression assessed the predictive power of ACE-III total score for neurocognitive disorder diagnosis.

Main Results:

• ACE-III subscale scores moderately to strongly predicted neuropsychological performance across constructs (p<0.001).
• Predictive accuracy of ACE-III was reduced in individuals with lower educational attainment.
• ACE-III total score was less sensitive than overall neuropsychological testing in predicting neurocognitive disorders.

Conclusions:

• ACE-III subscale scores correlate with neuropsychological measures assessing similar cognitive domains.
• Comprehensive neuropsychological testing is more sensitive for diagnosing neurocognitive disorders than the ACE-III total score alone.
• Full neuropsychological evaluation is recommended for patients with lower education, complex symptoms, or younger age.